Cytokinetics Inc (CYTK)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
8,989,255,000
EV to revenue ratio (TTM)
145.2
EV to ebitda
-15.82
Financial Performance
Revenue (TTM)
67,670,000
Gross profit (TTM)
-337,436,992
EBITDA
-695,361,984
Profitability
Operating margin (TTM)
-626.00%
Profit margin
0.00%
Return on assets (TTM)
-28.10%
Return on equity (TTM)
-572.00%
Per Share Metrics
Revenue per share (TTM)
0.54
EPS
-7.22
Diluted EPS (TTM)
-7.22
Book value
-1.25
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
117.65
PEG ratio
-0.42
Price to sales ratio (TTM)
132.84
Price to book ratio (TTM)
60.31
Growth
Quarterly earnings growth (YoY)
-57.10%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
7
Buy
13
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.36